ASCO 2019: 40-50 percent response rate for brigatinib after other next-gen ALK inhibitors
Credit: University of Colorado Cancer Center Crizotinib was the first drug licensed to treat ALK-positive non-small cell lung cancer (ALK+ ...
Tag: Health Professionals
ASCO: Oncologists see benefit of medical marijuana, but not comfortable prescribing
Credit: University of Colorado Cancer Center A University of Colorado Cancer Center study presented at the American Society for Clinical ...
ASCO: Entrectinib gets edge over crizotinib against ROS1+ lung cancer
Credit: University of Colorado Cancer Center Crizotinib and entrectinib are both active against ROS1+ non-small cell lung cancer. But which ...
LSU health research finds new RX target for common STD
Credit: LSU Health New Orleans New Orleans, LA - Research led by Ashok Aiyar, PhD, Associate Professor of Microbiology, Immunology ...
Media advisory: ‘Opioids: Conflicts & Controversies’
WASHINGTON (May 30, 2019) - PharmedOut, a Georgetown University Medical Center project that advances evidence-based prescribing and educates health care ...
Cannabis use among older adults rising rapidly
Study is first state-wide investigation of cannabis use among older Americans and the outcomes they experience AURORA, Colo. (May 30, ...
New study evaluates transcatheter dialysis conduit procedures over 15 years
Reston, VA (May 29, 2018) - A new research study by Harvey L. Neiman Health Policy Institute found that utilization ...
ASCO 2019: Delays lead to late-stage diagosis of young people with colorectal cancer
Credit: University of Colorado Cancer Center The incidence of early onset colorectal cancer has increased nearly 50 percent in the ...
Society for Endocrinology & British Thyroid Association issue statement against new treatment recommendation
The Society for Endocrinology (SfE) and British Thyroid Association (BTA) have issued a statement challenging recommendations made in a clinical ...
Lifting the lid on bladder cancer support
Flinders University develops new urology care modelCredit: Flinders University Bladder cancer is a painful and sometimes life-threatening condition that patients ...
Texture-modified foods for people with dysphagia
A piece of research by the UPV/EHU-University of the Basque Country is calling for an effort to bring various thickeners ...
Steroids can reduce lung cancer risk in COPD patients
Credit: Justin Ohata/UBC Faculty of Pharmaceutical Sciences For many people with chronic obstructive pulmonary disease or COPD, a steroid inhaler ...
Reinvent Motherisk to protect mothers and babies
Canada should reinvent the Motherisk program to support pregnant women to have healthy babies, argues an editorial in CMAJ (Canadian ...
Licorice tea causes hypertensive emergency in patient
Licorice tea, a popular herbal tea, is not without health risks, as a case study of a man admitted to ...
Many patients with pancreatic cancer miss out on treatment that may extend survival
Despite potential for prolonging survival with treatment, one-third of patients with metastatic pancreatic cancer do not see a medical oncologist, ...
Support needed for multiple-birth families to improve outcomes
The first-ever international collaborative report has compared the experiences of multiple-birth babies and their families to single-birth familiesCredit: Donnie Ray ...
New algorithm uses disease history to predict intensive care patients’ chances of survival
Researchers from the University of Copenhagen and Rigshospitalet have used data on more than 230,000 intensive care patients to develop ...
Embedded psychiatrist in pediatric clinic improves evaluation access, short-term treatment
BOSTON-- A novel method of embedding child psychiatric care in an urban pediatrics clinic was found to be feasible and ...
New in Ethics & Human Research, May-June 2019
Parent experiences when approached for research in a pediatric intensive care unit, the role of inclusion benefits in ethics committee ...
Children’s Tumor Foundation launches NF2 accelerator to combat rare genetic disorder
Foundation to invest $2.3 million to expand NF2 drug pipeline and accelerate treatments for neurofibromatosis type 2 patients On the ...
